299885
“State of The Science Update: Sexually Transmitted Infections"
Description: This session will focus on current CDC STI screening and treatment guidelines, identification of groups most at risk, and strategies for performing comprehensive sexual health histories on patients of all ages.
Lessons-learned: Health care providers often lack education and training in sexual health. Many patients are not being screened for sexually transmitted infections according to national guidelines. Absent or inadequate screening contributes to morbidity and hinders disease detection and prevention.
Implications/Recommendations: Health care providers must be aware of current national guidelines for sexually transmitted infection screening and treatment, including awareness of high risk groups. Individualized, non-judgmental discussions of sexual risk behavior are imperative to improve screening rates, defection of asymptomatic infections and prevention of disease sequelae. Access to care, accurate history taking, prompt diagnosis and treatment, and risk reduction education are necessary to reduce disease incidence and improve the sexual health of all persons across the lifespan.
Learning Areas:
Protection of the public in relation to communicable diseases including prevention or controlPublic health or related nursing
Public health or related research
Learning Objectives:
Describe the current recommendations for sexually transmitted infection screening based on age.
Keyword(s): STDs/STI
Qualified on the content I am responsible for because: I am a doctorally prepared women's health nurse practitioner with 17 years experience working in reproductive health. I have been the principal or co-investigator on internally and externally funded research examining sexual risk behaviors among men and women.
Any relevant financial relationships? Yes
Name of Organization | Clinical/Research Area | Type of relationship |
---|---|---|
Actavis Pharma | Women's Health | Advisory Committee/Board and Consultant |
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.